DPIIT recognised startup Government of India
Startup India
Medicament Innovation Private Limited
Medicament Innovation Private Limited - chemicals in Bhayandar, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2025
₹1.05 Cr
▲ 61% YoY
Net profit · FY 2025
₹28.66 Lakh
Net margin 27.2%
EBITDA · FY 2025
₹20.77 Lakh
EBITDA margin 19.7%
Authorised capital
₹30 Lakh
Registered with MCA
Paid-up capital
₹23 Lakh
Issued & subscribed
Open charges
₹24.5 Lakh
Secured borrowings
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
About Medicament Innovation Private Limited
Data last updated:
Medicament Innovation Private Limited is a private limited company based in Bhayandar, Maharashtra, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 28 July 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24239MH2022PTC387750.
The company has an authorised share capital of ₹30 Lakh and a paid-up capital of ₹23 Lakh. It is led by directors Mukesh Kumar and Saroj Devi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F – 23 Krishna Dham Near Hariom Jairaj Regal Ramdev Park Road Bhayandar (East), Maharashtra, India – 401107.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.05 Cr, a growth of 61% compared to the previous year. For the same year it recorded a net profit of ₹28.66 Lakh (net margin 27.2%) and EBITDA of ₹20.77 Lakh (EBITDA margin 19.7%).
As per MCA filings, the company has open charges of ₹24.5 Lakh on record.
Medicament Innovation Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-33-0228304).
Company details
CIN U24239MH2022PTC387750
Registration Number 387750
Incorporation Date 28 July 2022
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
MSME Classification Micro
Udyam Registration UDYAM-MH-33-0228304
Key People
Mukesh Kumar Director Saroj Devi Director Recognitions & Rankings of Medicament Innovation
MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-MH-33-0228304
Contact details
Medicament Innovation Private Limited's registered office is in Bhayandar, Maharashtra.
- Registered AddressF – 23 Krishna Dham Near Hariom Jairaj Regal Ramdev Park Road Bhayandar (East), Maharashtra, India – 401107
- IndustryChemicals, Manufacturing, Other Chemical Product
Comprehensive company report
Medicament Innovation Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Medicament Innovation is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Medicament Innovation Private Limited, buy the company report.
Financials of Medicament Innovation Private Limited
FY 2025 filings availableMedicament Innovation Private Limited reported revenue of ₹1.05 Cr (up 61% YoY) for FY 2025.
Revenue · FY 2025
₹1.05 Cr ▲ 61%
Net profit · FY 2025
₹28.66 Lakh margin 27.2%
EBITDA · FY 2025
₹20.77 Lakh margin 19.7%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 61%
EBITDA CAGR growth
1 year
▲ 136%
Revenue rose 61% in the latest year. EBITDA rose 136% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹20.77 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹28.66 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 19.7% | ||
| Net Profit Margin | 27.2% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Medicament Innovation Private Limited, buy the company report.
Board of directors of Medicament Innovation Private Limited
Medicament Innovation has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mukesh Kumar | Director | 28 Jul 2022 | 4 Years 3 Months | Current |
| Saroj Devi | Director | 19 Sep 2025 | 1 Years 1 Months | Current |
Peer comparison
Medicament Innovation Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Tulsi Mahapragya Products Private Limited | ₹1.06 Cr (FY 2025) | -62.0% | Coochbihar, West Bengal, India | |||
| Ancient Fragrances Private Limited | ₹1.06 Cr (FY 2024) | 27.0% | New Delhi, Delhi, India | |||
| Mother India Origin Nature Private Limited | ₹1.06 Cr (FY 2024) | 71.0% | Shaktifarm, Uttarakhand, India | |||
| Primero Life Sciences Private Limited | ₹1.06 Cr (FY 2025) | 106.0% | Hyderabad, Telangana, India | |||
| Anichem Industries Private Limited | ₹1.05 Cr (FY 2025) | 67.0% | Solapur, Maharashtra, India | |||
| Medicament Innovation Private Limitedthis company | ₹1.05 Cr (FY 2025) | ₹28.66 Lakh | 27.2% | 61.0% | Bhayandar, Maharashtra, India | |
| Aerochem Impex Private Limited | ₹1.05 Cr (FY 2019) | -21.0% | Telangana, India | |||
| Neusite Chem Private Limited | ₹1.05 Cr (FY 2025) | -10.0% | Ahmedabad, Gujarat, India | |||
| Aktachem Biotech Private Limited | ₹1.05 Cr (FY 2024) | -78.0% | Visakhapatnam, Andhra Pradesh, India | |||
| Kenbrio Pharmaceuticals Private Limited | ₹1.05 Cr (FY 2024) | -4.0% | Chandigarh, India | |||
| Sustainovate Industries Private Limited | ₹1.05 Cr (FY 2024) | Vadodara, Gujarat, India |
To see the full peer comparison of Medicament Innovation Private Limited, buy the company report.
Charges & borrowings
Open charges
₹24.5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 04 Jan 2023 | 100681315 | Others | ₹24.5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Medicament Innovation Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Medicament Innovation Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Medicament Innovation Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Medicament Innovation Private Limited has 5 board changes on record since 2022: 3 appointments and 2 cessations. The latest: Saroj Devi ceased to be Additional Director on 29 Sep 2025.
AGM
Medicament Innovation Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Ceased
Saroj Devi ceased to be Additional Director.
Ceased
Binod Amarnath Jha ceased to be Director.
Appointed
Saroj Devi was appointed as Director.
Filing
Medicament Innovation Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai Ii.
Charges
A charge with Others amounted to Rs. 24.50 Lakh with Charge ID 100681315 was registered on 04 Jan 2023.
Appointed
Binod Amarnath Jha was appointed as Director.
Appointed
Mukesh Kumar was appointed as Director.
Incorporation
28 Jul 2022
Medicament Innovation Private Limited was registered on 28 Jul 2022 with Roc Mumbai Ii & aged 4 years 3 months as per MCA records.
Frequently asked questions
Medicament Innovation is an active private limited company based in Bhayandar, Maharashtra, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 28 July 2022 (4+ years old) and is registered under CIN U24239MH2022PTC387750.
Medicament Innovation has 2 current directors:
- Mukesh Kumar - Director
- Saroj Devi - Director
The latest financial statements of Medicament Innovation on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The CIN (Corporate Identification Number) of Medicament Innovation is U24239MH2022PTC387750. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Medicament Innovation was incorporated on 28 July 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Medicament Innovation by revenue are Tulsi Mahapragya Products Private Limited, Ancient Fragrances Private Limited, Mother India Origin Nature Private Limited, Primero Life Sciences Private Limited, Anichem Industries Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Saroj Devi ceased to be Additional Director on 29 Sep 2025. Binod Amarnath Jha ceased to be Director on 19 Sep 2025. Saroj Devi was appointed as Director on 19 Sep 2025. Medicament Innovation has 5 board changes on record in total.
Yes, Medicament Innovation is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Medicament Innovation is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-33-0228304).
The registered office of Medicament Innovation is at F – 23 Krishna Dham Near Hariom Jairaj Regal Ramdev Park Road Bhayandar East, Maharashtra, India – 401107.
Medicament Innovation operates in the chemicals industry, in the manufacturing segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages